Int. J. Mol. Sci. 2012, 13(12), 15668-15678; doi:10.3390/ijms131215668
Article

Discovery of Novel Focal Adhesion Kinase Inhibitors Using a Hybrid Protocol of Virtual Screening Approach Based on Multicomplex-Based Pharmacophore and Molecular Docking

Fengbo Wu 1,† , Ting Xu 1,† email, Gu He 1,* email, Liang Ouyang 1 email, Bo Han 2 email, Cheng Peng 2,* email, Xiangrong Song 1 email and Mingli Xiang 1 email
1 Department of Pharmacy and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China 2 State Key Laboratory Breeding Base of Systematic research, Development and Utilization of Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 610041, China † These authors contributed equally to this work.
* Authors to whom correspondence should be addressed.
Received: 19 October 2012; in revised form: 9 November 2012 / Accepted: 19 November 2012 / Published: 23 November 2012
PDF Full-text Download PDF Full-Text [735 KB, uploaded 23 November 2012 12:11 CET]
Abstract: Focal adhesion kinase (FAK) is a tyrosine kinase that functions as a key orchestrator of signals leading to invasion and metastasis. In the current study, the multicomplex-based pharmacophore (MCBP)-guided method has been suggested to generate a comprehensive pharmacophore of FAK kinase based on seven crystal structures of FAK-inhibitor complexes. In this investigation, a hybrid protocol of virtual screening methods, comprising of pharmacophore model-based virtual screening (PB-VS) and docking-based virtual screening (DB-VS), is used for retrieving new FAK inhibitors from commercially available chemical databases. This hybrid virtual screening approach was then applied to screen several chemical databases, including the Specs (202,408 compounds) database. Thirty-five compounds were selected from the final hits and should be shifted to experimental studies. These results may provide important information for further research of novel FAK inhibitors.
Keywords: pharmacophore; molecular docking; focal adhesion kinase; virtual screening

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Wu, F.; Xu, T.; He, G.; Ouyang, L.; Han, B.; Peng, C.; Song, X.; Xiang, M. Discovery of Novel Focal Adhesion Kinase Inhibitors Using a Hybrid Protocol of Virtual Screening Approach Based on Multicomplex-Based Pharmacophore and Molecular Docking. Int. J. Mol. Sci. 2012, 13, 15668-15678.

AMA Style

Wu F, Xu T, He G, Ouyang L, Han B, Peng C, Song X, Xiang M. Discovery of Novel Focal Adhesion Kinase Inhibitors Using a Hybrid Protocol of Virtual Screening Approach Based on Multicomplex-Based Pharmacophore and Molecular Docking. International Journal of Molecular Sciences. 2012; 13(12):15668-15678.

Chicago/Turabian Style

Wu, Fengbo; Xu, Ting; He, Gu; Ouyang, Liang; Han, Bo; Peng, Cheng; Song, Xiangrong; Xiang, Mingli. 2012. "Discovery of Novel Focal Adhesion Kinase Inhibitors Using a Hybrid Protocol of Virtual Screening Approach Based on Multicomplex-Based Pharmacophore and Molecular Docking." Int. J. Mol. Sci. 13, no. 12: 15668-15678.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert